Evidence map›Paper›PMID 34135054›Full record

ReviewBMJ open2021

Rapid realist review of the role of community pharmacy in the public health response to COVID-19.

Ian Maidment, Emma Young, Maura MacPhee, Andrew Booth, Hadar Zaman, Juanita Breen, Andrea Hilton, Tony Kelly, Geoff Wong

Abstract readReview
In one paragraph

Review in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Social Attitudes Towards Public Health Interventions in Community Pharmacies in Poland: A Nationwide Cross-Sectional Survey.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  4. Review
  5. Article
  6. Availability, utilization, and factors associated with professional pharmacy services in community pharmacies in Saudi Arabia: a cross-sectional study.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Providing care to marginalised communities: a qualitative study of community pharmacy teams.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ian MaidmentCollege of Health and Life Sciences, Aston University, Birmingham, UK i.maidment@aston.ac.uk.ORCID 0000-0003-4152-9704
Emma YoungThe University of Sheffield, Sheffield, UK.
Maura MacPheeThe University of British Columbia, Vancouver, British Columbia, Canada.
Andrew BoothSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Hadar ZamanUniversity of Bradford, Bradford, UK.
Juanita BreenCollege of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia.
Andrea HiltonFaculty of Health Sciences, University of Hull, Hull, UK.
Tony KellyNHS Birmingham and Solihull Clinical Commissioning Group, Birmingham, UK.
Geoff WongPrimary Care Health Sciences, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCommunity pharmacists and their teams have remained accessible to the public providing essential services despite immense pressures during the COVID-19 pandemic. They have successfully expanded the influenza vaccination programme and are now supporting the delivery of the COVID-19 vaccination roll-out.

aimThis rapid realist review aims to understand how community pharmacy can most effectively deliver essential and advanced services, with a focus on vaccination, during the pandemic and in the future.

methodAn embryonic programme theory was generated using four diverse and complementary documents along with the expertise of the project team. Academic databases, preprint services and grey literature were searched and screened for documents meeting our inclusion criteria. The data were extracted from 103 documents to develop and refine a programme theory using a realist logic of analysis. Our analysis generated 13 context-mechanism-outcome configurations explaining when, why and how community pharmacy can support public health vaccination campaigns, maintain essential services during pandemics and capitalise on opportunities for expanded, sustainable public health service roles. The views of stakeholders including pharmacy users, pharmacists, pharmacy teams and other healthcare professionals were sought throughout to refine the 13 explanatory configurations.

resultsThe 13 context-mechanism-outcome configurations are organised according to decision makers, community pharmacy teams and community pharmacy users as key actors. Review findings include: supporting a clear role for community pharmacies in public health; clarifying pharmacists' legal and professional liabilities; involving pharmacy teams in service specification design; providing suitable guidance, adequate compensation and resources; and leveraging accessible, convenient locations of community pharmacy. DISCUSSION: Community pharmacy has been able to offer key services during the pandemic. Decision makers must endorse, articulate and support a clear public health role for community pharmacy. We provide key recommendations for decision makers to optimise such a role during these unprecedented times and in the future.

Indexed as

Community Pharmacy ServicesCOVID-19PharmaciesCOVID-19 VaccinesHumansPandemicsPharmacistsProfessional RolePublic HealthSARS-CoV-2COVID-19 VaccinesCOVID-19organisation of health servicesqualitative research

Identifiers

PMID34135054
PMCPMC8210681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.